"Fakultní nemocnice Hradec Králové náleží k největším zdravotnickým zařízením nejen ve východních Čechách, ale i v celé České republice. Na 39 pracovištích včetně 24 klinik s 1360 lůžky je každý rok hospitalizováno přes 41 tisíc pacientů, z nichž kolem 40 % je operováno. Ambulantně je v nemocnici ošetřeno okolo 700 tisíc pacientů. Jsou zde prováděny nejsložitější chirurgické výkony a používanými technologiemi v oblasti diagnostiky i léčby i léčebnými výsledky snese FN Hradec Králové srovnání s obdobnými nemocnicemi v Evropě. Fakultní nemocnice Hradec Králové je také významným výzkumným a výukovým pracovištěm úzce spojeným s Lékařskou fakultou UK v Hradci Králové."

During the past decade, Fakultni nemocnice Hradec Kralove-oddeleni klinicke hematologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 7 clinical trials were completed, i.e. on average, 175% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultni nemocnice Hradec Kralove-oddeleni klinicke hematologie" #1 collaborator was "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Fakultni nemocnice Hradec Kralove-oddeleni klinicke hematologie" are "Acute Myeloid Leukemia" (1 trials), "Anaplastic Large-Cell Lymphoma" (1 trials), "B-cell Lymphoma" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Diffuse Large B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Fakultni nemocnice Hradec Kralove-oddeleni klinicke hematologie" in a lesser frequency.

Most popular intervention types in "Fakultni nemocnice Hradec Kralove-oddeleni klinicke hematologie" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (4 trials), "brentuximab vedotin" (4 trials), "doxorubicin" (3 trials), "placebo" (3 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fakultni nemocnice Hradec Kralove-oddeleni klinicke hematologie" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Fakultni nemocnice Hradec Kralove-oddeleni klinicke hematologie". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Fakultni nemocnice Hradec Kralove-oddeleni klinicke hematologie, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Fakultni nemocnice Hradec Kralove-oddeleni klinicke hematologie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".